We detected the expression of PRMT1 via immunohistochemical staining of clinical samples from three major subtypes of conventional OS (osteoblastic, chondroblastic and fibroblastic) and two types of benign bone tumours (osteoid osteoma and chondroblastoma). This evidence concerns the gene PRMT1 and bone benign neoplasm.